Advances in soft mist inhalers

V Komalla, CYJ Wong, I Sibum… - Expert Opinion on …, 2023 - Taylor & Francis
ABSTRACT Introduction Soft mist inhalers (SMIs) are propellant-free inhalers that utilize
mechanical power to deliver single or multiple doses of inhalable drug aerosols in the form …

Will “air eutrophication” increase the risk of ecological threat to public health?

YF Sun, Y Guo, C Xu, Y Liu, X Zhao, Q Liu… - Environmental …, 2023 - ACS Publications
Aquatic eutrophication, often with anthropogenic causes, facilitates blooms of cyanobacteria
including cyanotoxin producing species, which profoundly impact aquatic ecosystems and …

Tolerability and immunogenicity of an intranasally-administered adenovirus-vectored COVID-19 vaccine: An open-label partially-randomised ascending dose phase I …

M Madhavan, AJ Ritchie, J Aboagye, D Jenkin… - …, 2022 - thelancet.com
Background Intranasal vaccination may induce protective local and systemic immune
responses against respiratory pathogens. A number of intranasal SARS-CoV-2 vaccine …

Mucosal boosting enhances vaccine protection against SARS-CoV-2 in macaques

K McMahan, F Wegmann, M Aid, M Sciacca, J Liu… - Nature, 2024 - nature.com
A limitation of current SARS-CoV-2 vaccines is that they provide minimal protection against
infection with current Omicron subvariants,, although they still provide protection against …

Viral-vectored respiratory mucosal vaccine strategies

M Jeyanathan, S Afkhami, A Kang, Z Xing - Current Opinion in Immunology, 2023 - Elsevier
Increasing global concerns of pandemic respiratory viruses highlight the importance of
developing optimal vaccination strategies that encompass vaccine platform, delivery route …

Adenoviral-vectored next-generation respiratory mucosal vaccines against COVID-19

S Afkhami, A Kang, V Jeyanathan, Z Xing… - Current Opinion in …, 2023 - Elsevier
The world is in need of next-generation COVID-19 vaccines. Although first-generation
injectable COVID-19 vaccines continue to be critical tools in controlling the current global …

Next generation mucosal vaccine strategy for respiratory pathogens

F Dotiwala, AK Upadhyay - Vaccines, 2023 - mdpi.com
Inducing humoral and cytotoxic mucosal immunity at the sites of pathogen entry has the
potential to prevent the infection from getting established. This is different from systemic …

Inhalation of vaccines and antiviral drugs to fight respiratory virus infections: reasons to prioritize the pulmonary route of administration

R Heida, HW Frijlink, WLJ Hinrichs - Mbio, 2023 - Am Soc Microbiol
Many of the current pandemic threats are caused by viruses that infect the respiratory tract.
Remarkably though, the majority of vaccines and antiviral drugs are administered via …

Design considerations for intratracheal delivery devices to achieve proof-of-concept dry powder biopharmaceutical delivery in mice

M Manser, V Jeyanathan, M Jeyanathan, X Feng… - Pharmaceutical …, 2023 - Springer
Purpose Intratracheal delivery and consistent dosing of dry powder vaccines is especially
challenging in mice. To address this issue, device design of positive pressure dosators and …

[HTML][HTML] Durable immunity to SARS-CoV-2 in both lower and upper airways achieved with a gorilla adenovirus (GRAd) S-2P vaccine in non-human primates

JI Moliva, SF Andrew, BJ Flynn, DA Wagner, KE Foulds… - bioRxiv, 2023 - ncbi.nlm.nih.gov
SARS-CoV-2 continues to pose a global threat, and current vaccines, while effective against
severe illness, fall short in preventing transmission. To address this challenge, there's a …